Lsamp gene associated with cardiovascular disease

The LSAMP gene can be used for cardiovascular disease risk assessment, in particular Left Main Disease. The genetic risk attributable to LSAMP adds to known cardiovascular disease risk factors. Assessment of risk attributable to LSAMP permits early initiation of preventive and therapeutic strategies. Given the pronounced clinical risk associated with Left Main Disease, such risk assessment should significantly reduce morbidity and mortality.

Patents:
US 20,110,070,583

Inventor(s): VANCE JEFFERY M [US]; GOLDSCHMIDT PASCAL [US]; HAUSER ELIZABETH [US]; KRAUS WILLIAM [US]; PERICAK-VANCE MARGARET A [US]

Type of Offer: Licensing



« More Genetics Patents

---